Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.596,57
-0,06%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Melinta Therapeutics Inc (MLNT) Melinta Therapeutics Inc (MLNT) Notizie

MLNT

Melinta Therapeutics (MLNT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MLNT
DataOraFonteTitoloSimboloCompagnia
24/06/202022:02GlobeNewswire Inc.Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of TetraphaseNASDAQ:MLNTMelinta Therapeutics Inc
09/06/202022:02GlobeNewswire Inc.Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase PharmaceuticalsNASDAQ:MLNTMelinta Therapeutics Inc
04/03/202022:03GlobeNewswire Inc.Melinta Therapeutics Confirms Deerfield as Successful Bidder for CompanyNASDAQ:MLNTMelinta Therapeutics Inc
13/02/202022:02GlobeNewswire Inc.Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding ProceduresNASDAQ:MLNTMelinta Therapeutics Inc
05/02/202017:15Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MLNTMelinta Therapeutics Inc
08/01/202022:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
27/12/201915:02GlobeNewswire Inc.Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit FacilityNASDAQ:MLNTMelinta Therapeutics Inc
12/11/201923:07GlobeNewswire Inc.Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019NASDAQ:MLNTMelinta Therapeutics Inc
12/11/201923:00Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNTMelinta Therapeutics Inc
25/10/201918:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
24/10/201922:02GlobeNewswire Inc.Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Tr...NASDAQ:MLNTMelinta Therapeutics Inc
01/10/201916:07PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019NASDAQ:MLNTMelinta Therapeutics Inc
03/09/201922:05GlobeNewswire Inc.Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and DirectorNASDAQ:MLNTMelinta Therapeutics Inc
13/08/201912:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MLNTMelinta Therapeutics Inc
09/08/201913:31GlobeNewswire Inc.Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession PlanNASDAQ:MLNTMelinta Therapeutics Inc
09/08/201913:30GlobeNewswire Inc.Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business UpdateNASDAQ:MLNTMelinta Therapeutics Inc
06/08/201923:04GlobeNewswire Inc.Melinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results ReportingNASDAQ:MLNTMelinta Therapeutics Inc
16/07/201913:30GlobeNewswire Inc.Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:MLNTMelinta Therapeutics Inc
10/07/201921:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MLNTMelinta Therapeutics Inc
01/07/201915:13PR Newswire (US)X-Biotix Therapeutics Joins Antimicrobials Working GroupNASDAQ:MLNTMelinta Therapeutics Inc
26/06/201922:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNTMelinta Therapeutics Inc
20/06/201917:13PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2019NASDAQ:MLNTMelinta Therapeutics Inc
19/06/201913:30GlobeNewswire Inc.Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the ...NASDAQ:MLNTMelinta Therapeutics Inc
07/06/201915:27PR Newswire (US)Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Inno...NASDAQ:MLNTMelinta Therapeutics Inc
16/05/201923:31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MLNTMelinta Therapeutics Inc
09/05/201922:00GlobeNewswire Inc.Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:MLNTMelinta Therapeutics Inc
07/05/201913:30GlobeNewswire Inc.Melinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual MeetingNASDAQ:MLNTMelinta Therapeutics Inc
02/05/201922:30GlobeNewswire Inc.Melinta Therapeutics to Report First Quarter 2019 Financial Results on May 9, 2019NASDAQ:MLNTMelinta Therapeutics Inc
30/04/201912:18Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MLNTMelinta Therapeutics Inc
12/04/201916:08PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology a...NASDAQ:MLNTMelinta Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MLNT

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
NEXI
Nexi S.p.A
BIT
TIT
Telecom Italia
BIT
PST
Poste Italiane S.p.a
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network